INTRODUCTION Chronic kidney disease (CKD)
is a well -recognized and an independent cardiovascular risk factor. 1-3 First described by Japanese authors in the 1990s, takotsubo syndrome (TTS; also known as takotsubo cardiomyopathy) presents as an acute myocardial infarction, occurs usually in connection with a stressful situation, and is characterized by severe left ventricular dysfunction. 4 -6 TTS is observed mainly in women. Generally, patients with TTS have a normal coronary angiogram and left ventricular dysfunction that recovers within days or weeks. The prognosis was recognized as benign, but a few studies have demonstrated that mortality is higher than previously thought. 4,5
ORIGINAL ARTICLE
Takotsubo syndrome and chronic kidney disease: a deadly duet in long -term follow -up CI -AKI was not observed in any of the patients. Compared with patients without CKD, those with CKD stages 3 and 4 were older but less often had a positive family history of cardiovascular disease and did not have hyperthyroidism (TABLE 2) . On coronary angiography, CKD patients more frequently had insignificant coronary atherosclerotic lesions. On electrocardiography, they more often had atrial fibrillation and significantly longer QTc interval on hospital admission, but there was no difference in ST -segment elevation between groups. However, after a few days of hospitalization, pronounced negative T waves were observed less frequently in patients with CKD than in those without. CKD patients had significantly higher creatine kinase activity and concentrations of fibrinogen and C -reactive protein.
During hospitalization, sudden cardiac arrest was diagnosed significantly more frequently in patients with CKD than in non-CKD population. In -hospital, 1 -year, and 3 -year mortality rates were significantly higher in patients with CKD (FIGURE 1).
The pharmacological treatment did not differ significantly between groups. Patients with CKD more often used fondaparinux, whereas acetylsalicylic acid and β -blockers were administered less frequently than in non-CKD population. The remaining data are presented in TABLE 3.
In the multivariate analysis in the logistic regression model, the predictors of death were as follows: low body mass index (OR, 0.694; 95% CI, 0.558-0.8630; P = 0.001), low left ventricular ejection fraction (OR, 0.889; 95% CI, 0.807-0.980; P = 0.02), and elevated serum creatinine levels (OR, 13.813; 95% CI, 1.8-105.9; P = 0.01). DISCUSSION TTS was first described less than 30 years ago. Its pathomechanism has not yet been fully elucidated. For years, TTS was believed to be a benign disease with favorable outcomes.
PATIENTS AND METHODS
This was a retrospective study, in which data of 101 patients with a diagnosis of TTS were collected in 5 cardiology centers in Podlasie Province in Poland. In 95 patients, TTS was confirmed according to the Mayo Clinic criteria. 6 There were no exclusion criteria in the study. All the patients were admitted to the invasive cardiology department for coronary angiography due to suspicion of acute myocardial infarction. In all cases, creatinine concentrations were measured on admission and after coronary angiography to check for the presence of contrast -induced AKI (CI -AKI).
CKD (defined as an estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m 2 ) was classified according to Kidney Disease Improving Global Outcomes criteria. 11 For further analyses, patients were divided into 2 groups according to eGFR levels (calculated by the CKD -EPI formula): 30 patients (32%) with eGFR of less than 60 ml/min/1.73 m 2 and 65 patients (68%) with eGFR of 60 ml/min/1.73 m 2 or higher. The endpoint was all -cause mortality.
The study protocol was approved by the local ethics committee. Patients gave their written informed consent to participate in the study. The mean follow -up duration was 3.2 years, and its completion was possible owing to the database of Podlaski Urząd Wojewódzki (Podlasie Province Office).
Statistical analysis Data distribution was tested with the Shapiro-Wilk test. Quantitative data were compared with the t test and Mann-Whitney test, and qualitative data were analyzed by the χ 2 test and Fisher exact test. Survival analysis was performed with the Kaplan-Meier method. The multifactor analysis was conducted with the logistic regression method. In the multivariate analysis, factors of significant prognostic importance in patients after acute coronary syndromes were included (age, sex, hypertension, hyperlipidemia, family history, sudden cardiac arrest, body mass index, hemoglobin, creatine kinase, leukocytes, creatinine, and eGFR). A P value of less than 0.05 was considered significant. The statistical analysis was performed using the STATISTICA 13.1 program (Tulsa, Oklahoma, United States). However, a relatively high mortality of patients with TTS in comparison with those with myocardial infarction has been reported recently. 4,5,12 CKD is the recognized cardiovascular risk factor. It also adversely affects the prognosis of severe heart failure and ventricular arrhythmias, as well as with higher in -hospital mortality. In their study, 65.5% of patients underwent coronary angiography. Patients with renal dysfunction more frequently required mechanical ventilation, catecholamine administration, intra--aortic ballon contrapulsation or extracorporeal membrane oxygenation. Similar results were obtained by Murakami et al. 17 In the study of Santoro et al, 15 TTS patients with CKD required prolonged hospitalization; in addition, patients with CKD stage 4 had higher mortality rates, more frequent recurrence of TTS, and more frequent hospitalizations for other causes. It should be emphasized that TTS is no longer considered a benign disease. Both short-and long -term mortality rates are much higher than those in patients with ST -segment elevation myocardial infarction (STEMI) or non-ST -segment elevation myocardial infarction (NSTEMI). 18 -22 In -hospital mortality of patients with TTS and CKD in our study was 6.7%, while in NSTEMI patients with CKD treated with percutaneous coronary intervention in the United States, the in--hospital mortality rate was only 2%. 18 In patients aged over 75 years with STEMI and CKD, long -term mortality (mean follow -up, 898 days) was 9%, while in the group aged 75 to 85 years, it was 31%. 19 In our study, the mean age of patients with TTS and CKD was 75 years, with female predominance (87%). It was in contrast to the STEMI and NTEMI populations. In Chinese patients with TTS and CKD undergoing primary percutaneous coronary intervention, 30 -day mortality was 4.08%, 1 -year mortality was 7.95%, and renal dysfunction (both CKD [19.7%] and AKI [29.5%]) developed in 49% of patients, whereas in a Korean study by Shin et al, 8 7 of 30 patients with stress -induced cardiomyopathy had renal dysfunction (4 on hemodialysis and 3 with AKI). 16 Other studies on TTS did not assess kidney function, serum creatinine levels, or eGFR.
Of note, mortality in our CKD population with TTS was high and reached 33.3% during long -term follow -up (mean, 3.2 years). CKD proved to be the strongest predictor of mortality, outweighing low left ventricular ejection fraction. Bill et al 14 reported that 5 -year mortality was 43.7% for patients with TTS and an eGFR of less than 60 ml/min/1.73m 2 in comparison with 22.3% for those with an eGFR of 60 ml/min/1.73 m 2 or higher. However, they found no differences in baseline characteristics between patients with and without kidney dysfunction, no differences in the rates of life--threatening arrhythmias, cardiogenic shock, cardiopulmonary resuscitation, and thromboembolic events. In our study, we presented much more detailed characteristics of patients. Importantly, although CKD patients had a lower prevalence of positive family history of cardiovascular disease, mortality rates were significantly higher at long -term follow -up. In addition, sudden cardiac arrest was more common in the CKD population. All studied patients underwent coronary angiography, but none of them developed CI -AKI. This finding has not been reported by previous studies. 14- 17 Ando et al 16 showed that renal dysfunction in TTS was associated with the development of For commercial use, please contact the journal office at pamw@mp.pl.
long -term mortality (mean follow -up, 335 days) was 16.33%, which was comparable with mortality of CKD patients in our study. 20 Margolis et al 21 reported that long -term mortality (mean follow -up, 1170 days) in STEMI patients with CKD was 17.6%, as compared with 2.7% in patients without CKD. In Polish Registry of Acute Coronary Syndromes, the mortality rate for STEMI patients with CKD was 6.9% at 1 year and 24.5% at 3 years; in the NSTEMI population, the mortality was 6.1% at 1 year and 13.9% at 3 years. 22 It clearly shows that TTS, particularly in patients with impaired kidney function, is a fatal disease.
Both the pathogenesis of TTS and effect of impaired kidney function on the outcomes of TTS patients have not been fully explained so far. It may be speculated that elevated catecholamine concentrations in CKD could contribute to the development of secondary TTS, and it may also have an adverse effect on TTS prognosis. 23, 24 The main limitation of our study is the small number of patients; however, we collected data for all available patients in north -eastern Poland in the last years. Another limitation is the retrospective study design. In an observational study, information about the causes of deaths was not collected, so all -cause mortality was accepted as the main endpoint.
In conclusion, CKD is a novel and still underestimated risk factor for unfavorable TTS outcomes. It may not only be a trigger of TTS, but, more importantly, it has a major adverse impact on prognosis. It should also be stressed that CKD is the strongest predictor of mortality in TTS. Thus, the assessment of kidney function is important in all patients with TTS, not only to assess the risk of short--term and long -term morbidity and mortality but also to adjust drug doses and implement preventive measures to avoid CI -AKI when coronary angiography or contrast -enhanced computed tomography is scheduled.
